WMS Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,908
| Closed | -$310K | – | 291 |
|
|
2022
Q3 | $310K | Sell |
3,908
-2,106
| -35% | -$167K | 0.04% | 186 |
|
|
2022
Q2 | $447K | Buy |
6,014
+2,885
| +92% | +$214K | 0.07% | 147 |
|
|
2022
Q1 | $281K | Buy |
3,129
+1,125
| +56% | +$101K | 0.04% | 193 |
|
|
2021
Q4 | $224K | Hold |
2,004
| – | – | 0.05% | 192 |
|
|
2021
Q3 | $252K | Hold |
2,004
| – | – | 0.04% | 232 |
|
|
2021
Q2 | $271K | Buy |
2,004
+125
| +7% | +$16.9K | 0.04% | 214 |
|
|
2021
Q1 | $255K | Hold |
1,879
| – | – | 0.06% | 188 |
|
|
2020
Q4 | $265K | Hold |
1,879
| – | – | 0.05% | 199 |
|
|
2020
Q3 | $209K | Hold |
1,879
| – | – | 0.04% | 214 |
|
|
2020
Q2 | $210K | Buy |
+1,879
| New | +$210K | 0.04% | 197 |
|
|
2020
Q1 | – | Sell |
-6,435
| Closed | -$612K | – | 225 |
|
|
2019
Q4 | $612K | Buy |
+6,435
| New | +$612K | 0.14% | 91 |
|